NAD+ Therapy (Nicotinamide Adenine Dinucleotide)

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every cell of the body. It plays a central role in cellular energy production, mitochondrial function, and DNA repair.
Levels of NAD+ decline with age and metabolic stress.

- Mitochondrial ATP production
- Sirtuin activation (cellular repair pathways)
- Oxidative stress regulation
- Cellular metabolism

- Low energy
- Recovery from metabolic stress
- Age-related decline in cellular function
Appropriateness is determined after physician evaluation.

Compounded NAD+ is not FDA-approved for the diagnosis, treatment, cure, or prevention of disease. Therapy is prescribed based on individualized medical judgment.

- Subcutaneous or intramuscular administration
- Individualized dosing
- Ongoing monitoring as clinically indicated

Initial medical consultation: $99
If therapy is appropriate, medication pricing is discussed transparently before prescribing.
How It Works
You’ll begin with a brief virtual consultation with a licensed medical provider, who will review your medical history and determine whether this therapy may be appropriate for you.
If treatment is recommended, your prescription is sent to a licensed U.S. compounding pharmacy and shipped directly to your home, typically within 3–7 business days.
Consultation Cost
The total cost is $300, which includes:


If a peptide therapy is not clinically appropriate, there is no charge for the visit.
- All therapies are prescribed only when clinically appropriate and based on physician evaluation.
Frequently Asked Questions
Compounded NAD+ is not FDA-approved for the diagnosis, treatment, cure, or prevention of disease. It may be prescribed based on individualized medical evaluation.
NAD+ may be legally prescribed by a licensed physician through a compounding pharmacy when deemed clinically appropriate.
NAD+ is typically administered via subcutaneous or intramuscular injection, depending on physician recommendation.
Individuals with certain medical conditions, or those who are pregnant or breastfeeding, should only consider NAD+ after physician evaluation.